Literature DB >> 12410521

Transcatheter patch occlusion of experimental atrial septal defects.

Eleftherios B Sideris1, Chrysoula E Sideris, Stamatis F Stamatelopoulos, Spyridon D Moulopoulos.   

Abstract

The effectiveness and safety of transcatheter patch atrial septal defect (ASD) occlusion were studied in 20 piglets. Experimental atrial septal defects were created by foramen ovale dilation. ASDs were corrected by polyurethane patches of two types (flat and sleeve). Specially made balloon catheters supported the patches for periods varying from 1 to 6 days; after this period, the supporting catheters were withdrawn and the patches were released. All transcatheter patches were safely embedded in the atrial septum 48 hr or more after implantation. All defects were fully occluded. One patch became infected. The transcatheter patch experimental ASD occlusion method was found effective and safe, potentially applicable in the occlusion of human ASDs. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12410521     DOI: 10.1002/ccd.10333

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  4 in total

Review 1.  Closing down: transcatheter closure of intracardiac defects and vessel embolisations.

Authors:  Jean-François Piéchaud
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

2.  Total percutaneous correction of a tetralogy of Fallot variant with dominant pulmonary valve stenosis.

Authors:  E B Sideris; B Macuil; S Justiniano; P S Rao
Journal:  Heart       Date:  2005-03       Impact factor: 5.994

3.  A Novel Approach for the Retrieval of Broken Catheter Fragment - Using Balloon Dilatation Technique.

Authors:  Padmakumar Ramachandran; Rohith Poondru Reddy; M Sudhakar Rao; Ashwal Adamane Jayaram
Journal:  J Clin Diagn Res       Date:  2016-03-01

4.  Closure of interatrial defects by immediate-release patch.

Authors:  Aliakbar Zeinaloo; Keyhan Sayadpour Zanjani; Bahman Rastkar; Alimohammad Hajizeinali; Bahram Sohrabi; Mahmoud Samadi; Eleftherios B Sideris
Journal:  Pediatr Cardiol       Date:  2012-03-28       Impact factor: 1.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.